Sanofi options Recursion drug candidate, triggering $10M payment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. ELV
10. NDAQ

Go back to Sanofi options Recursion drug candidate, triggering $10M payment

Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration

October 15, 2026 8:45 AM EDT

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (Recursion) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development decoding biology to radically improve lives, today announced that Sanofi has optioned the first development candidate from the two companies multi-program research collaboration.

... More